is tirzepatide no longer available FDA Says Compounded Must Exit the Market FDA sets tirzepatide compounding deadlines

The combination commonly produces severe constipation, persistent nausea, and slowed recovery

Yes, it may increase during dose escalation, which is why GLP-1 medicines are introduced gradually

ILAP application guidance GOV.UK

These pens clearly display the prescribed dose in milligrams (mg) on a simple dial and not units, allowing straightforward subcutaneous administration once weekly into the abdomen, thigh, or upper arm without needing syringes. Never attempt to extract semaglutide from Ozempic pens using syringes, as the pens internal design and different concentrations can lead to a significant risk of dosing errors often 5 to 20 times the intended amount due to misreading syringe markings or misunderstanding volume

Thigh : Inject into the front or side of your thigh